Last updated: 22 July 2019 at 6:40am EST

Management Group Viii L L C... Net Worth




The estimated Net Worth of Management Group Viii L L C... is at least 813 千$ dollars as of 10 August 2005. Management C owns over 86,317 units of Atricure Inc stock worth over 312,497$ and over the last 19 years Management sold ATRC stock worth over 500,639$.

Management C ATRC stock SEC Form 4 insiders trading

Management has made over 1 trades of the Atricure Inc stock since 2005, according to the Form 4 filled with the SEC. Most recently Management sold 86,317 units of ATRC stock worth 500,639$ on 10 August 2005.

The largest trade Management's ever made was selling 86,317 units of Atricure Inc stock on 10 August 2005 worth over 500,639$. On average, Management trades about 86,317 units every 0 days since 2005. As of 10 August 2005 Management still owns at least 11,617 units of Atricure Inc stock.

You can see the complete history of Management C stock trades at the bottom of the page.



Insiders trading at Atricure Inc

Over the last 19 years, insiders at Atricure Inc have traded over 52,789,242$ worth of Atricure Inc stock and bought 666,621 units worth 5,937,195$ . The most active insiders traders include Scott William DrakeGroup I, Llc Donoghue Danie...Management Group Viii L L C.... On average, Atricure Inc executives and independent directors trade stock every 24 days with the average trade being worth of 548,410$. The most recent stock trade was executed by Maggie Yuen on 15 August 2024, trading 3,500 units of ATRC stock currently worth 84,245$.



What does Atricure Inc do?

atricure, inc. provides innovative technologies for the treatment of afib and related conditions. afib affects more than 33 million people worldwide. electrophysiologists and cardiothoracic surgeons around the globe use atricure technologies for the treatment of afib and reduction of afib related complications. atricure’s isolator® synergy™ ablation system is the first and only medical device to receive fda approval for the treatment of persistent afib. atricure’s atriclip left atrial appendage exclusion system products are the most widely sold laa management devices worldwide, with more than 100,000 implanted to date. for more information, visit atricure.com or follow us on twitter @atricure.



Complete history of Management C stock trades at Atricure Inc

インサイダー
取引
取引
合計金額
Management Group Viii L L C...
販売 500,639$
10 Aug 2005


Atricure Inc executives and stock owners

Atricure Inc executives and other stock owners filed with the SEC include: